| Autor: |
Alhajeri H; Mubarak Al-Kabeer Hospital, Jabriya, Kuwait. hebah.alhajeri@gmail.com., Abutiban F; Al Jahra Hospital, Al Jahra, Kuwait., Al-Adsani W; Mubarak Al-Kabeer Hospital, Jabriya, Kuwait., Al-Awadhi A; Department of Medicine, Kuwait University, Kuwait City, Kuwait., Aldei A; Al Amiri Hospital, Kuwait City, Kuwait., AlEnizi A; Al Jahra Hospital, Al Jahra, Kuwait., Alhadhood N; Farwaniya Hospital, Al Farwaniya, Kuwait., Al-Herz A; Al Amiri Hospital, Kuwait City, Kuwait., Alkandari W; Farwaniya Hospital, Al Farwaniya, Kuwait., Dehrab A; Adan Hospital, Hadiya, Kuwait., Muhanna Ghanem AA; Mubarak Al-Kabeer Hospital, Jabriya, Kuwait., Hasan E; Al Amiri Hospital, Kuwait City, Kuwait., Hayat S; Mubarak Al-Kabeer Hospital, Jabriya, Kuwait., Saleh K; Farwaniya Hospital, Al Farwaniya, Kuwait., Tarakmeh H; Mubarak Al-Kabeer Hospital, Jabriya, Kuwait., Ali Y; Mubarak Al-Kabeer Hospital, Jabriya, Kuwait. |
| Abstrakt: |
The Kuwait Association of Rheumatology (KAR) aimed to develop a set of recommendations for the treatment of patients with rheumatoid arthritis (RA), tailored to the unique patient population and healthcare system of Kuwait. Each recommendation was developed based on expert opinion and evaluation of clinical practice guidelines from other international and national rheumatology societies. Online surveys were conducted to collate feedback on each KAR member's level of agreement (LoA) with definitions of disease-/treatment-related terms used and the draft recommendations. Definitions/recommendations achieving a pre-defined cut-off value of ≥ 70% agreement were accepted for inclusion. Remaining statements were discussed and revised at a face-to-face meeting, with further modifications until consensus was reached. A final online survey was used to collect feedback on each KAR member's LoA with the final set of recommendation statements on a scale of 0 (complete disagreement) to 10 (complete agreement). Group consensus was achieved on 66 recommendation statements, including 3 overarching principles addressing the pharmacological treatment and management of RA. Recommendations focused on treatment of early RA, established RA, patients with high-risk comorbidities, women during pregnancy and breastfeeding, and screening and treatment of opportunistic infections. The KAR 2018 Treatment Recommendations for RA reported here are based on a synthesis of other national/international guidelines, supporting literature, and expert consensus considering the Kuwaiti healthcare system and RA patient population. These recommendations aim to inform the clinical decisions of rheumatologists treating patients in Kuwait, and to promote best practices, enhance alignment and improve the treatment experience for patients. |
Full text from SpringerLink